• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    CeriBell, Inc. - Common Stock (NQ:CBLL)

    22.43 -0.36 (-1.60%)
    Streaming Delayed Price Updated: 10:53 AM EST, Jan 14, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 63,262
    Open 22.74
    Bid (Size) 22.42 (200)
    Ask (Size) 22.59 (100)
    Prev. Close 22.79
    Today's Range 22.40 - 22.74
    52wk Range 10.01 - 26.04
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution
    Clearance would position the Ceribell System as the first and only point-of-care electroencephalography (EEG) technology to aid in detection and monitoring of Large Vessel Occlusion (LVO) stroke in the... 
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare Conference
    From Ceribell
    Via GlobeNewswire

    Performance

    YTD
    +5.3%
    +5.3%
    1 Month
    +2.4%
    +2.4%
    3 Month
    +80.0%
    +80.0%
    6 Month
    +42.6%
    +42.6%
    1 Year
    +7.6%
    +7.6%

    More News

    Read More
    News headline image
    Global AI Infrastructure Shift Ignites Biotech Growth Phase
    From USA News Group
    Via GlobeNewswire
    News headline image
    Earnings Scheduled For November 4, 2025 ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For August 5, 2025 ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For May 8, 2025 ↗
    Via Benzinga
    News headline image
    Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for Neonates
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference
    From Ceribell
    Via GlobeNewswire
    News headline image
    CeriBell (CBLL) Q3 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings Economy World Trade
    News headline image
    Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell Reports Third Quarter 2025 Financial Results
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell to Report Third Quarter 2025 Financial Results on November 4, 2025
    From Ceribell
    Via GlobeNewswire
    News headline image
    Medtech Leader Erica Rogers Joins Ceribell Board of Directors
    From Ceribell
    Via GlobeNewswire
    News headline image
    CeriBell (CBLL) Q2 Revenue Jumps 38% ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Ceribell Reports Second Quarter 2025 Financial Results
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell to Participate in the Canaccord Genuity 45th Annual Growth Conference
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell to Report Second Quarter 2025 Financial Results on August 5, 2025
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell Files Complaints Against Natus Medical Incorporated with the U.S. International Trade Commission and Federal Court in Delaware
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell Reports First Quarter 2025 Financial Results
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell Receives FedRAMP® High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell to Report First Quarter 2025 Financial Results on May 8, 2025
    From Ceribell
    Via GlobeNewswire
    News headline image
    FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older
    From Ceribell
    Via GlobeNewswire

    Frequently Asked Questions

    Is CeriBell, Inc. - Common Stock publicly traded?
    Yes, CeriBell, Inc. - Common Stock is publicly traded.
    What exchange does CeriBell, Inc. - Common Stock trade on?
    CeriBell, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for CeriBell, Inc. - Common Stock?
    The ticker symbol for CeriBell, Inc. - Common Stock is CBLL on the Nasdaq Stock Market
    What is the current price of CeriBell, Inc. - Common Stock?
    The current price of CeriBell, Inc. - Common Stock is 22.43
    When was CeriBell, Inc. - Common Stock last traded?
    The last trade of CeriBell, Inc. - Common Stock was at 01/14/26 10:53 AM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.